Latest Breaking News On - Harald seifert - Page 1 : comparemela.com

Revolutionary Treatments Emerge for Bloodstream Infections

Revolutionary Treatments Emerge for Bloodstream Infections
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Sachsen anhaltHarald seifertAchim kaaschInfection researchInstitute for medical microbiologyOtto von guericke university of magdeburgUniversity hospital cologneHead of the institute for medical microbiologyGerman research foundationGerman centerMedical microbiologyHospital hygieneGuericke universityLancet infectiousProfessor seifertGerman research

Study finds early switch to oral antibiotic therapy for S aureus bloodstream infections is safe, effective

Study finds early switch to oral antibiotic therapy for S aureus bloodstream infections is safe, effective
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Sachsen anhaltHarald seifertAchimj kaaschAchim kaaschHead of the institute for medical microbiologyInfection researchOtto von guericke university of magdeburgUniversity hospital cologneGerman centerInstitute for medical microbiologyMedical microbiologyHospital hygieneGuericke universityLancet infectious diseasesProfessor seifertLancet infectious

ERADICATE phase 3 study results highlight the potential

Late breaker presentation at IDWeek 2022First double-blind registrational phase 3 study in Staphylococcus aureus bacteremiaCeftobiprole non-inferior to.

Basel stadtUnited statesMikael saulayMarc engelhardtSarahb doernbergSarae cosgroveTimothyc jenkinsDaniel ionescuIvan titovNicholasa turnerHarald seifertVanceg fowler jrBoiko atanasovOleksandr pavlovMaziar assadi gehrThomasl holland

Basilea Pharmaceutica AG: Basilea announces late breaking presentation on the successfully completed ERADICATE phase 3 study with ceftobiprole in Staphylococcus aureus bacteremia (SAB) at IDWeek 2022

First presentation of ERADICATE phase 3 study dataStudy met its primary and secondary endpoints comparing ceftobiprole versus daptomycin with or without aztreonam Basel/Allschwil, Switzerland, October

United statesSouth africaBasel stadtRepublic of south africaNils schrMikael saulayMarc engelhardtSarahb doernbergSarae cosgroveDaniel ionescuTimothyc jenkinsIvan titovNicholasa turnerHarald seifertVanceg fowler jrBoiko atanasov